IRIS
MEGNA, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 15.403
NA - Nord America 10.638
EU - Europa 9.744
SA - Sud America 1.851
AF - Africa 371
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 9
AN - Antartide 1
Totale 38.041
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.218
SG - Singapore 6.758
RU - Federazione Russa 4.398
CN - Cina 3.244
VN - Vietnam 2.268
DE - Germania 1.865
BR - Brasile 1.507
IT - Italia 1.407
HK - Hong Kong 1.242
FR - Francia 554
IN - India 504
NL - Olanda 333
KR - Corea 291
JP - Giappone 263
GB - Regno Unito 242
BD - Bangladesh 218
FI - Finlandia 204
CA - Canada 195
IE - Irlanda 161
AR - Argentina 136
MX - Messico 135
UA - Ucraina 100
IQ - Iraq 89
ZA - Sudafrica 89
CI - Costa d'Avorio 84
PL - Polonia 83
ES - Italia 78
SE - Svezia 73
EC - Ecuador 61
PH - Filippine 59
PK - Pakistan 55
TR - Turchia 55
TH - Thailandia 53
ID - Indonesia 52
AT - Austria 49
TW - Taiwan 40
MA - Marocco 37
CO - Colombia 32
BG - Bulgaria 29
VE - Venezuela 27
KE - Kenya 24
LT - Lituania 24
PY - Paraguay 24
EG - Egitto 22
SA - Arabia Saudita 22
CL - Cile 21
PE - Perù 19
UZ - Uzbekistan 19
JO - Giordania 18
AU - Australia 17
RO - Romania 17
MY - Malesia 16
TN - Tunisia 16
UY - Uruguay 16
OM - Oman 15
CZ - Repubblica Ceca 14
JM - Giamaica 14
BE - Belgio 13
DZ - Algeria 13
ET - Etiopia 13
CH - Svizzera 12
GR - Grecia 12
AE - Emirati Arabi Uniti 11
DO - Repubblica Dominicana 11
CR - Costa Rica 10
DK - Danimarca 10
IL - Israele 10
RS - Serbia 10
AZ - Azerbaigian 9
CM - Camerun 9
IR - Iran 9
KZ - Kazakistan 9
LB - Libano 9
NP - Nepal 9
TT - Trinidad e Tobago 9
PA - Panama 8
SN - Senegal 8
BB - Barbados 7
BO - Bolivia 7
SY - Repubblica araba siriana 7
AL - Albania 6
GT - Guatemala 6
HR - Croazia 6
KH - Cambogia 6
NI - Nicaragua 6
PS - Palestinian Territory 6
PT - Portogallo 6
AM - Armenia 5
CG - Congo 5
CY - Cipro 5
EE - Estonia 5
HU - Ungheria 5
KG - Kirghizistan 5
SC - Seychelles 5
EU - Europa 4
HN - Honduras 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
LY - Libia 4
QA - Qatar 4
Totale 37.932
Salva come PNG Salva come JPEG
Città #
Singapore 3.356
San Jose 1.956
Hefei 1.311
Hong Kong 1.181
Moscow 1.137
Ashburn 1.081
Chandler 688
Beijing 668
Ho Chi Minh City 654
Santa Clara 615
Hanoi 513
Krefeld 387
Lauterbourg 348
The Dalles 332
Los Angeles 317
Seoul 255
Amsterdam 251
Naples 231
Tokyo 228
Kochi 222
Napoli 188
Dallas 185
New York 181
Boston 178
Bad Bellingen 171
Millbury 168
Redondo Beach 158
Buffalo 150
Lawrence 146
Des Moines 137
São Paulo 135
Munich 114
Council Bluffs 108
Milan 95
Da Nang 92
Frankfurt am Main 91
Nanjing 86
Seattle 83
Haiphong 75
Houston 73
Orem 73
Helsinki 72
Mexico City 72
Rome 66
Wilmington 65
Brooklyn 64
Dublin 63
Princeton 58
Chicago 57
Montreal 55
Chennai 53
Rio de Janeiro 53
Warsaw 53
Falkenstein 52
London 50
Nuremberg 46
Atlanta 44
Dong Ket 44
Fairfield 44
Toronto 44
Turku 44
Düsseldorf 43
Denver 42
Guangzhou 41
Boardman 40
Biên Hòa 39
San Francisco 39
Lappeenranta 38
Menlo Park 34
Washington 34
Hải Dương 33
Johannesburg 33
Phoenix 32
Poplar 32
Stockholm 32
Woodbridge 31
Can Tho 30
Baghdad 28
Belo Horizonte 28
Nanchang 28
Brasília 27
Kronberg 27
Sofia 27
Mumbai 25
Shanghai 25
Curitiba 23
Nairobi 23
Ottawa 23
Paris 23
Pune 23
Arezzo 22
Guayaquil 21
Shenyang 21
Ankara 20
Bengaluru 20
Campinas 20
Porto Alegre 20
Manchester 19
New Delhi 19
Tashkent 19
Totale 20.621
Salva come PNG Salva come JPEG
Nome #
Secukinumab in Hidradenitis Suppurativa Patients Who Failed Adalimumab: A 52-Week Real-Life Study 394
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort 380
Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses – IL PSO (Italian landscape psoriasis) 369
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS) 362
A case of aquagenic wrinkling of the palms 244
A case of the co-existence of subcorneal pustular dermatosis and pyoderma gangrenosum and a review of the literature 200
Very low-calorie ketogenic diet (VLCKD) in patients with psoriasis and obesity: an update for dermatologists and nutritionists 197
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review 179
Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications 174
An indolent nasal form of primary cutaneous CD8-positive peripheral T-cell lymphoma not otherwise specified successfully treated with local radiation therapy- a new subtype? 173
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence 170
Psoriasis and sport: a new ally? 166
Generalized violaceous maculopapular rash and multiple verrucous nodules on the testes: a case of secondary syphilis misdiagnosed as lymphoma 165
"Active" photoprotection: sunscreens with DNA repair enzymes. A review of the literature 164
Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist 158
What's new about atopic dermatitis and sporting activity 157
Persistent candidiasis infection during anti‐ IL ‐17 treatment for plaque psoriasis requiring biologic discontinuation: a case series and literature review 156
Efficacy and safety of risankizumab in psoriasis patients who failed anti‐IL‐17, anti‐12/23 and/or anti IL‐23: preliminary data of a real‐life 16‐week retrospective study 156
Generalized Pustular Psoriasis rapidly and successfully treated with Ixekizumab in a Caucasian patient 156
Skin diseases and visual arts 155
Chronic inducible urticarias in children 152
The effect of the ketogenic diet on Acne: Could it be a therapeutic tool? 150
Possible role of BMP-4 in the hyper-pigmentation of psoriatic plaques after anti-TNF-α treatment 150
Psoriasis Features in Patients with Inflammatory Bowel Disease 149
Hypersensitivity reaction to certolizumab pegol in a patient affected by psoriatic arthritis 148
Adult atopic dermatitis: a review 146
Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study 143
Appearances may be deceiving 143
Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data 141
The Role of Thermal Water in Chronic Skin Diseases Management: A Review of the Literature 141
Hidradenitis suppurativa: guidelines of the Italian Society of Dermatology and Venereology (SIDeMaST) for the use of anti-TNF-α agents. 139
A case of psoriatic alopecia secondary to certolizumab pegol: clinical and trichoscopic evaluation 139
Cutaneous leucocytoclastic vasculitis during secukinumab treatment 138
Management of Psoriasis Patients with Serious Infectious Diseases 137
QuantiFERON TB‐gold conversion rate among psoriasis patients under biologics: a 9‐year retrospective study 137
Cutaneus sarcoidosis small-fiber neuropathy resembling leprosy: a case report 136
Tattooing and hidradenitis suppurativa: stigmatization and camouflage 135
Psoriatic arthritis and psoriasis: differential diagnosis 135
Acne prevalence in 9 to 14-year-old old patients attending pediatric ambulatory clinics in Italy 135
Skin diseases and tattoos: A five-year experience 135
L'avvento degli inibitori delle proteasi nella terapia dell'infezione da epatite C: Reazioni avverse dermatologiche 134
Systemic treatment for psoriasis and malignancies: A real risk? 134
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience 133
Neutrophilic dermatosis in pregnancy: An uncommon course 133
Apremilast efficacy and safety in elderly psoriasis patients over a 48-weeks period 133
Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears 133
Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity? 133
Real-world practice indirect comparison between guselkumab, risankizumab and tildrakizumab: results from an Italian 28-week retrospective study 133
Insulin Resistance and Skin Diseases 132
Eczematous drug eruption in patients with psoriasis under anti‐interleukin‐17A: does interleukin‐22 play a key role? 132
Psoriasis in a cohort of patients with common variable immunodeficiency 131
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients 130
The use of ChatGPT in the dermatological field: a narrative review 129
Infantile Acute Generalized Pustular Psoriasis: A Case Report 129
Erythrodermic Pityriasis Rubra Pilaris treatment: two case reports and literature review 129
Ciprofloxacin-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient 129
Corrigendum: A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab (Clin Cosmet Investig Dermatol. (2023), 16, (3503–3507), 10.2147/CCID.S447123) 128
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients 128
Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis) 127
Anterior Cervical Hypertrichosis: A Case Report and Review of the Literature. 127
Photodynamic Therapy and Skin Appendage Disorders: A Review 127
Dermoscopic patterns of intradermal naevi 127
Erythrodermic psoriasis successfully and rapidly treated with brodalumab: report of two cases 127
16-year real-life study on the prevalence of mycoses in a paediatric population 127
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review 126
A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab 126
The impact of COVID ‐19 infection on psoriatic patients treated with biologics: an Italian experience 126
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study 126
Pyoderma gangrenosum successfully treated with topical tacrolimus 126
Immunocytometric analysis of COVID patients: A contribution to personalized therapy? 126
Melanoma frequency among symmetrical Spitzoid-looking lesions: a retrospective study 125
Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience 125
Ixekizumab: an efficacious treatment for both psoriasis and hidradenitis suppurativa 125
Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II 125
Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study 124
Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features 123
Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature 123
Melanocytic nevi in children of southern Italy: dermoscopic, constitutional, and environmental factors. 123
Impact of current anti-psoriatic systemic treatments on male and female fertility: what the endocrinologist needs to know 123
A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23 123
Irisin, a novel metabolic biomarker in hidradenitis suppurativa: correlation with clinical responsivity to anti-TNF-α therapy 122
Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge 122
Chronic hand Eczema: Is IL-36á helpful in diagnosis and classification? 122
A case of Stewart-Treves Syndrome of the lower limbs: The usefulness of dermoscopy 122
Teledermatology for acne during COVID-19: high patients' satisfaction in spite of the emergency 122
QuantiFERON TB-gold conversion is not uncommon in psoriasis patients under anti-TNF-α 122
Garbage and skin diseases related risk. 121
Rowell Syndrome: A Diagnostic Challenge 121
Leg paralysis after photodynamic therapy for Lymphomatoid Papulosis: a case report 121
Teledermatology: a useful tool also after Covid-19 era? 120
Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab 119
Tildrakizumab for the treatment of moderate to severe psoriasis: results from a single center preliminary real‐life study 119
A case of linear psoriasis in a young patient with Down syndrome and review of the literature 119
The Impact of Psoriasis Treatments on the Risk of Skin Cancer: A Narrative Review 119
Risk Factors for Psoriasis Flares: A Narrative Review 118
Efficacy of JAK inhibitors in the treatment of psoriasiform atopic dermatitis 118
Drug safety evaluation of ixekizumab for psoriasis: a review of the current knowledge 117
Psoriasis in elderly and non elderly population: clinical and molecular features. 117
Primary bilateral malignant melanoma of the lower limbs 117
Risankizumab in real life: preliminary results of efficacy and safety in psoriasis during a 16-week period 117
Totale 14.619
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.510
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 0 0 0 0 0 0 59
2021/20221.301 22 32 21 44 39 52 30 92 155 103 219 492
2022/20232.027 234 168 66 93 211 201 72 207 311 254 165 45
2023/20243.132 101 238 225 143 111 213 58 187 1.287 73 344 152
2024/202510.538 468 590 81 85 266 587 980 769 802 1.378 3.645 887
2025/202620.264 2.170 2.269 2.190 2.030 3.066 798 2.167 1.303 2.314 1.125 679 153
Totale 38.715